FactSet to Participate in UBS Financial Services Virtual Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailNORWALK, Conn., Aug. 03, 2021 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS | NASDAQ: FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, today announced that it will participate in the UBS Virtual Financial Services Conference on Tuesday, August 10, 2021.
Helen Shan, Chief Financial Officer and Chief Revenue Officer will participate in a fireside chat at 10:00 a.m. EDT. A live webcast will be available on the Company’s investor relations website. A replay will also be available for one year following the event.
About FactSet
FactSet (NYSE:FDS | NASDAQ: FDS) delivers superior content, analytics, and flexible technology to help more than 155,000 users see and seize opportunity sooner. We give investment professionals the edge to outperform with informed insights, workflow solutions across the portfolio lifecycle, and industry-leading support from dedicated specialists. We're proud to have been recognized with multiple awards for our analytical and data-driven solutions and repeatedly scored 100 by the Human Rights Campaign® Corporate Equality Index for our LGBTQ+ inclusive policies and practices. Subscribe to our thought leadership blog to get fresh insight delivered daily at insight.factset.com. Learn more at www.factset.com and follow us on Twitter: www.twitter.com/factset.
Media & Investor Relations:
Rima Hyder+1.857.265.7523[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
- Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and
- Cryptocurrency News: Solana Goes 85x Faster as Pepeto Early Buyers Line Up for a Run
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
UBS, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
